123 related articles for article (PubMed ID: 120017)
1. Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells.
Thomas JM; Carver FM; Thomas FT
Surg Forum; 1979; 30():282-3. PubMed ID: 120017
[No Abstract] [Full Text] [Related]
2. Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells.
Thomas JM; Carver FM; Burnett CM; Thomas FT
Transplant Proc; 1981 Mar; 13(1 Pt 1):599-602. PubMed ID: 7022896
[No Abstract] [Full Text] [Related]
3. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys.
Thomas JM; Carver FM; Foil MB; Hall WR; Adams C; Fahrenbruch GB; Thomas FT
Transplantation; 1983 Jul; 36(1):104-6. PubMed ID: 6346606
[No Abstract] [Full Text] [Related]
4. Cardiac allograft survival in rhesus primates treated with total lymphoid irradiation and rabbit antithymocyte globulin.
Bieber CP; Jamieson SW; Raney A; Burton NA; Bogarty S; Hoppe R; Kaplan HS; Strober S; Stinson EB
Surg Forum; 1979; 30():284-6. PubMed ID: 120018
[No Abstract] [Full Text] [Related]
5. Induction of cytotoxic (sensitization) and enhancing (prolonged survival) responses by injection of lymphoid cells in ALS-treated mice.
Wood ML; Monaco AP
Transplant Proc; 1979 Jun; 11(2):1456-7. PubMed ID: 382539
[No Abstract] [Full Text] [Related]
6. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of specific unresponsiveness to skin allografts by spleen cells from ALS-treated, marrow-injected mice.
Wood ML; Monaco AP
Transplant Proc; 1979 Mar; 11(1):1023-7. PubMed ID: 377604
[No Abstract] [Full Text] [Related]
8. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
[TBL] [Abstract][Full Text] [Related]
9. Whole antilymphocyte serum: a potent safe immunosuppressive agent for intravenous use in man.
Levey RH; Parkman R
Transplant Proc; 1977 Mar; 9(1):1019-22. PubMed ID: 405764
[TBL] [Abstract][Full Text] [Related]
10. Critical factors in the quality control of antilymphocyte globulin (ALG).
Thomas F; Thomas J; Millington G; Doane J; Mendez-Picon G; Lee HM
Proc Clin Dial Transplant Forum; 1977; 7():134-40. PubMed ID: 98763
[No Abstract] [Full Text] [Related]
11. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. I. In vivo parameters and immunohistologic evidence suggesting microchimerism.
Thomas J; Carver M; Cunningham P; Park K; Gonder J; Thomas F
Transplantation; 1987 Mar; 43(3):332-8. PubMed ID: 3103273
[TBL] [Abstract][Full Text] [Related]
12. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
[TBL] [Abstract][Full Text] [Related]
13. Effect of the treatment of parental cells in vitro with anti-T antibody on bone marrow transplantation in F1 hybrid mice.
Hrubá A; Paluska E; Fricová V; Fiala J
Folia Biol (Praha); 1980; 26(5):338-50. PubMed ID: 7002637
[TBL] [Abstract][Full Text] [Related]
14. Effect of posttransplantation administration of peripheral blood lymphocytes in skin-grafted mice treated with antilymphocyte serum or antilymphocyte serum plus bone marrow.
De Fazio SR; Hartner WC; Monaco AP; Gozzo JJ
Transplantation; 1987 Jul; 44(1):70-5. PubMed ID: 3299924
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing reconstitution by bone marrow transplantation.
van Bekkum DW; Wielenga JJ; van Gils F; Wagemaker G
Prog Clin Biol Res; 1990; 352():479-91. PubMed ID: 1698302
[TBL] [Abstract][Full Text] [Related]
16. GVHD suppression by incubation of bone marrow grafts with anti-T-cell globulin: effect in the canine model and application to clinical bone marrow transplantation.
Rodt H; Kolb HJ; Netzel B; Rieder I; Janka G; Belohradsky B; Haas RJ; Thierfelder S
Transplant Proc; 1979 Mar; 11(1):962-6. PubMed ID: 377731
[No Abstract] [Full Text] [Related]
17. A comparison of in vitro, immunosuppressive and clinical effects of goat and horse anti-human thymocyte globulin in Macaca monkeys.
Kelly GE; Sheil AG; Mears DC
Clin Exp Immunol; 1973 Apr; 13(4):585-94. PubMed ID: 4197827
[TBL] [Abstract][Full Text] [Related]
18. Immunofluorescent assay of anti-human thymocyte globulin as a means of correlating "in vitro" and "in vivo" activity.
Ablin RJ; Morrell RM
Dev Biol Stand; 1974; 27():223-8. PubMed ID: 4618534
[No Abstract] [Full Text] [Related]
19. Preparation and immunosuppressive potency of equine anti-human thymocyte membrane IgG.
Diethelm AG; Chambers LM; Balch CM; Phillips SJ
Postgrad Med J; 1976; 52(5 Suppl):55-8. PubMed ID: 825846
[TBL] [Abstract][Full Text] [Related]
20. Use of allogenic, homozygous bone marrow cells for the induction of specific immunologic tolerance in mice treated with antilymphocyte serum.
Gozzo JJ; Wood ML; Monaco AP
Surg Forum; 1970; 21():281-4. PubMed ID: 4936984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
